All the following steps, including cDNA synthesis, library preparation and equalization, template preparation, sequencing and post-run analysis were fully automated on the Genexus system.
The samples were sequenced on two Ion Torrent™ GX5™ Chip. The sequencing run was performed by using the Ion AmpliSeq SARS-CoV-2 Research Panel on the Genexus Integrated Sequencer (ThermoFisher Scientific, San Diego, CA), according to two preinstalled assays: “SARS-CoV-2 Low Titer Research Assay” for samples with viral load < 200 copies and “SARS-CoV-2 Research Assay” for > 200 copies.
The Ion AmpliSeq SARS-CoV-2 Research Panel consists of 2 primer pools targeting 237 amplicons tiled across the SARS-CoV-2 genome, with an additional 5 primer pairs targeting human expression controls. The SARS-CoV-2 amplicons range from 125 to 275 bp in length.
Post-sequencing run analysis was performed by Genexus Software with following plug-in: COVID19AnnotateSnpEff for variant annotation, IRMA for genome-assisted and Trinity for de novo sequence assembly.